Wall Street Associates’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-40,000
Closed -$721K 337
2015
Q3
$721K Hold
40,000
0.14% 185
2015
Q2
$1.03M Hold
40,000
0.1% 203
2015
Q1
$876K Buy
+40,000
New +$863K 0.08% 216

Other funds holding ENTL

Wall Street Associates's ENTL Position: Q4 2015 in Review

Wall Street Associates sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2015, closing a stake of 40,000 shares — an estimated $721K sold.

Wall Street Associates first reported a position in ENTL in Q1 2015 and held it in 3 quarters. The position peaked at $1.03M in Q2 2015. 52 funds tracked by Wall St. Rank hold ENTL as of Q4 2015.

  • Wall Street Associates reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Wall Street Associates sold 40,000 Entellus Medical, Inc. Common Stock shares in Q4 2015, an estimated $721K.
  • Wall Street Associates first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Wall Street Associates's Entellus Medical, Inc. Common Stock position peaked at $1.03M in Q2 2015.
  • 52 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2015.

Based on Wall Street Associates's 13F filing for Q4 2015, filed 11 Feb 2016.